Rob Righi

Vice president and general manager, Vascular Platform, Peripheral Intervention at BD

Appears in 1 story

Last updated Oct 31, 2026

Stories

BD launches expandable liver shunt stent graft in the U.S.

New Capabilities

Leads BD's interventional portfolio including the Liverty launch

BD began selling a liver shunt device in the U.S. on October 28, 2026. The Liverty lets physicians choose the shunt's diameter during the procedure, from 6 to 10 millimeters, after receiving CE Mark approval in Europe in April 2026.

Updated Oct 31